CONMED Corporation (NASDAQ: CNMD) and Asante Solutions (NASDAQ:PUMP) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitabiliy, institutional ownership, risk, valuation, dividends, earnings and analyst recommendations.

Valuation and Earnings

This table compares CONMED Corporation and Asante Solutions’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
CONMED Corporation $772.61 million 1.79 $123.91 million $0.56 88.61
Asante Solutions $520.92 million 1.94 $19.74 million N/A N/A

CONMED Corporation has higher revenue and earnings than Asante Solutions.


CONMED Corporation pays an annual dividend of $0.80 per share and has a dividend yield of 1.6%. Asante Solutions does not pay a dividend. CONMED Corporation pays out 142.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.


This table compares CONMED Corporation and Asante Solutions’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
CONMED Corporation 2.02% 8.38% 3.66%
Asante Solutions -2,766.48% N/A -208.12%

Analyst Recommendations

This is a summary of current recommendations and price targets for CONMED Corporation and Asante Solutions, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CONMED Corporation 0 2 1 0 2.33
Asante Solutions 1 1 10 1 2.85

CONMED Corporation presently has a consensus price target of $49.33, indicating a potential downside of 0.58%. Asante Solutions has a consensus price target of $19.00, indicating a potential upside of 55.74%. Given Asante Solutions’ stronger consensus rating and higher probable upside, analysts clearly believe Asante Solutions is more favorable than CONMED Corporation.

Institutional & Insider Ownership

99.8% of CONMED Corporation shares are owned by institutional investors. 2.6% of CONMED Corporation shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.


CONMED Corporation beats Asante Solutions on 8 of the 14 factors compared between the two stocks.

About CONMED Corporation

CONMED Corporation is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. The Company provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. The Company’s product lines consist of orthopedic surgery, general surgery and surgical visualization. As of December 31, 2016, the Company’s products are distributed domestically directly to over 6,000 hospitals, surgery centers and other healthcare institutions, as well as through medical specialty distributors. The Company’s orthopedic surgery product lines include sports medicine, powered surgical instruments, and sports biologics and tissue. These products are marketed under a range of brands, including Hall, CONMED Linvatec, Concept and Shutt.

About Asante Solutions

Asante Solutions, Inc. is a medical device company. The Company is a manufacturer of Asante Snap Insulin Pump System (Snap system), which is a pump featuring a modular design with pre-filled insulin cartridges and disposable pump bodies, utilized in combination with a controller. The Snap system comprises four components: the Snap system controller, a disposable pump body, disposable pre-filled insulin cartridges and disposable infusion sets. The Snap system also incorporates a technology that allows for auto-priming, whereby, without user intervention, the infusion tubing is automatically filled with insulin every time a new cartridge is inserted. The disposable pump body, which contains a fresh battery, is designed to be used for a week. The Company markets the Snap system through distributors of medical equipment and supplies to individuals with diabetes.

Receive News & Ratings for CONMED Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CONMED Corporation and related companies with's FREE daily email newsletter.